Author

B. S. Pollard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

G. A. Prince· 1 shared H. B. Pollard· 1 shared H. Caohuy· 1 shared J. C. Blanco· 1 shared J. R. Pollard· 1 shared N. I. Walton· 1 shared O. Eidelman· 1 shared Q. Yang· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

G. A. Prince

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Inflammation in the COVID-19 airway is due to inhibition of CFTR signaling by the SARS-CoV-2 Spike protein

H. Caohuy, O. Eidelman, T. Chen, Q. Yang, B. S. Pollard, N. I. Walton, H. B. Pollard

This paper shows that SARS-CoV-2 Spike protein inhibits CFTR signaling in airway epithelia, leading to inflammation similar to cystic fibrosis.

bioRxiv · Jan 18, 2022Microbiology

Classical drug digitoxin inhibits influenza cytokine storm, with implications for COVID-19 therapy.

B. S. Pollard, J. C. Blanco, J. R. Pollard, G. A. Prince

The paper shows that digitoxin reduces cytokine storm in influenza-infected cotton rats, suggesting potential therapeutic use for influenza and coronavirus infections.

bioRxiv · Apr 9, 2020Immunology